ArticlePloS one2026
The impact of multimorbidity on the occurrence of depression among middle-aged and elderly people in China.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the association between multimorbidity and the incidence of depression in the middle-aged and elderly populations in China, focusing on the impact of multiple chronic diseases on mental health outcomes.
methodsThis research comprises a rigorous retrospective cohort study utilizing the esteemed China Health and Retirement Longitudinal Study (CHARLS) data. Follow-up data were meticulously analyzed from 2013 (Wave 2) to 2020 (Wave 5), with data from 2015 serving as the essential baseline for examining multimorbidity and depression. We employed Directed Acyclic Graphs (DAGs) to identify potential confounding factors, applying overlap weighting to effectively mitigate their influence, thus ensuring that intergroup comparisons mirror the integrity of a randomized trial. The association between multimorbidity and depression was systematically evaluated through Cox regression models, supplemented by thorough subgroup analyses and sensitivity analyses to confirm the robustness of our findings.
resultsOur analysis included 3,495 participants aged 45 and older. Multimorbidity was found to significantly elevate the risk of depression (Hazard Ratio [HR] = 1.431, 95% Confidence Interval [CI] 1.202-1.703). This risk was particularly pronounced in women (HR = 1.617, 95% CI: 1.290-2.027) and older adults (HR = 1.482, 95% CI: 1.221-1.799). The risk of depression increased with the number of chronic diseases, particularly with two (HR = 1.423, 95% CI: 1.192-1.701) or three (HR = 2.045, 95% CI: 1.503-2.784) chronic conditions. However, this association diminished in significance when four chronic conditions were present (HR = 0.815, 95% CI: 0.444-1.497).
conclusionThe pronounced association between multimorbidity and depression in middle-aged and elderly individuals highlights an urgent public health issue, particularly for women and older adults. This study's use of overlap weighting provides strong evidence of the substantial impact of multimorbidity on mental health. It underscores the immediate need for targeted interventions to improve mental well-being in these vulnerable groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.